Matrix Metalloproteinase-9 Gene -1562C/T Polymorphism Mitigates Preeclampsia

Placenta

Volumn 28, Issue 7, 2007, Pages 709-713

  Coolman, M ^a   de Maat, M ^a   Van Heerde, W L ^b   Felida, L ^a   Schoormans, S ^b   Steegers, E A P ^a   Bertina, R M ^c   de Groot, C J M ^a,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

Annexin A5; Apoptosis; Metalloproteinases; Placentation; Preeclampsia

Indexed keywords

CYTOSINE; GELATINASE B; LIPOCORTIN 5; STROMELYSIN; THYMINE;

ALLELE; APOPTOSIS; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DECIDUA; FEMALE; FETOPLACENTAL UNIT; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; HUMAN TISSUE; HYPOTHESIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; TROPHOBLAST;

ADULT; ALLELES; ANNEXIN A5; CASE-CONTROL STUDIES; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; PROMOTER REGIONS (GENETICS);

EID: 34249808183     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2006.06.017     Document Type: Article

References (30)

1. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 (2005) 1592-1594
2. Steegers-Theunissen R.P., and Steegers E.A. Nutrient-gene interactions in early pregnancy: a vascular hypothesis. Eur J Obstet Gynecol Reprod Biol 106 (2003) 115-117
3. Wang Y., Lewis D.F., Gu Y., Zhang Y., Alexander J.S., and Granger D.N. Placental trophoblast-derived factors diminish endothelial barrier function. J Clin Endocrinol Metab 89 (2004) 2421-2428
4. Blankenship T.N., Enders A.C., and King B.F. Trophoblastic invasion and modification of uterine veins during placental development in macaques. Cell Tissue Res 274 (1993) 135-144
5. Librach C.L., Werb Z., Fitzgerald M.L., Chiu K., Corwin N.M., Esteves R.A., et al. 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol. 113 2 (1991) 437-449
6. Bischof P., and Campana A. Molecular mediators of implantation. Baillieres Best Pract Res Clin Obstet Gynaecol 14 (2000) 801-814
7. Shimonovitz S., Hurwitz A., Dushnik M., Anteby E., Geva-Eldar T., and Yagel S. Developmental regulation of the expression of 72 and 92 kd type IV collagenases in human trophoblasts: a possible mechanism for control of trophoblast invasion. Am J Obstet Gynecol 171 (1994) 832-838
8. Coppock H.A., White A., Aplin J.D., and Westwood M. Matrix metalloprotease-3 and -9 proteolyze insulin-like growth factor-binding protein-1. Biol Reprod 71 (2004) 438-443
9. Merchant S.J., and Davidge S.T. The role of matrix metalloproteinases in vascular function: implications for normal pregnancy and pre-eclampsia. Br J Gynaecol 111 (2004) 931-939
10. Rand J.H., Wu X.X., Guller S., Scher J., Andree H.A., and Lockwood C.J. Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi. Am J Obstet Gynecol 177 (1997) 918-923
11. Shu F., Sugimura M., Kanayama N., Kobayashi H., Kobayashi T., and Terao T. Immunohistochemical study of annexin V expression in placentae of preeclampsia. Gynecol Obstet Invest 49 (2000) 17-23
12. Zhang B., Ye S., Herrmann S.M., Eriksson P., de Maat M., Evans A., et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99 (1999) 1788-1794
13. Ye S., Eriksson P., Hamsten A., Kurkinen M., Humphries S.E., and Henney A.M. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 271 (1996) 13055-13060
14. Gonzalez-Conejero R., Corral J., Roldan V., Martinez C., Marin F., Rivera J., et al. A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients. Blood 100 (2002) 2081-2086
15. De Groot C.J., Bloemenkamp K.W., Duvekot E.J., Helmerhorst F.M., Bertina R.M., van der Meer F., et al. Preeclampsia and genetic risk factors for thrombosis: a case-control study. Am J Obstet Gynecol 181 (1999) 975-980
16. Zhang B., Henney A., Eriksson P., Hamsten A., Watkins H., and Ye S. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet 105 (1999) 418-423
17. de Jager C.A., Linton E.A., Spyropoulou I., Sargent I.L., and Redman C.W. Matrix metalloprotease-9, placental syncytiotrophoblast and the endothelial dysfunction of pre-eclampsia. Placenta 24 (2003) 84-91
18. Huisman M.A., Timmer A., Zeinstra M., Serlier E.K., Hanemaaijer R., Goor H., et al. Matrix-metalloproteinase activity in first trimester placental bed biopsies in further complicated and uncomplicated pregnancies. Placenta 25 (2004) 253-258
19. Tayebjee M.H., Karalis I., Nadar S.K., Beevers D.G., MacFadyen R.J., and Lip G.Y. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension. Am J Hypertens 18 (2005) 325-329
20. Blankenberg S., Rupprecht H.J., Poirier O., Bickel C., Smieja M., Hafner, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107 (2003) 1579-1585
21. Thompson M.M., and Squire I.B. Matrix metalloproteinase-9 expression after myocardial infarction: physiological or pathological?. Cardiovasc Res 54 (2002) 495-498
22. Apple F.S., Wu A.H., Mair J., Ravkilde J., Panteghini M., Tate J., et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 51 (2005) 810-824
23. Smith G.C., Pell J.P., and Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 357 (2001) 2002-2006
24. Pasterkamp G., Schoneveld A.H., Hijnen D.J., de Kleijn D.P., Teepen H., van der Wal A.C., et al. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis 150 2 (2000) 245-253
25. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90 3 (2002) 251-262
26. Huppertz B., and Kingdom J.C. Apoptosis in the trophoblast-role of apoptosis in placental morphogenesis. J Soc Gynecol Invest 11 6 (2004) 353-362
27. Gaugler-Senden I.P., Roes E.M., de Groot C.J.M., and Steegers E.A.P. Clinical risk factors for preeclampsia. Eur Clinics Obstet Gynaecol 1 (2005) 36-50
28. Terashima M., Akita H., Kanazawa K., Inoue N., Yamada S., Ito K., et al. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction. Circulation 99 (1999) 2717-2719
29. Galewska Z., Bankowski E., Romanowicz L., and Jaworski S. Pre-eclampsia (EPH-gestosis)-induced decrease of MMP-s content in the umbilical cord artery. Clin Chim Acta 335 (2003) 109-115
30. Pollanen P.J., Lehtimaki T., Mikkelsson J., Ilveskoski E., Kunnas T., Perola M., et al. Matrix metalloproteinase 3 and 9 gene promoter polymorphisms: joint action of two loci as a risk factor for coronary artery complicated plaques. Atherosclerosis 180 (2005) 73-78